An Open-Label Prospective Study to Investigate the safety, efficacy and tolerability of Quetiapine in Adolescents and Adults experiencing their first Psychotic Episode in an Australian Health Care Set (2004–2005)

Grant type:
AstraZeneca Pty Ltd
Researchers:
Funded by:
AstraZeneca Pty Ltd